These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 60057)

  • 1. Quantitation of antibodies to Herpes simplex virus types 1 and 2 by complement-dependent antibody lysis of infected cells.
    McClung H; Seth P; Rawls WE
    Am J Epidemiol; 1976 Aug; 104(2):181-91. PubMed ID: 60057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative concentrations in human sera of antibodies to cross-reacting and specific antigens of Herpes simplex virus types 1 and 2.
    McClung H; Seth P; Rawls WE
    Am J Epidemiol; 1976 Aug; 104(2):192-201. PubMed ID: 60058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuraminidase reversal of resistance to lysis of herpes simplex virus-infected cells by antibody and complement.
    Tompkins WA; Seth P; Gee S; Rawls WE
    J Immunol; 1976 Feb; 116(2):489-95. PubMed ID: 175118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera.
    Subramanian T; Rawls WE
    J Clin Microbiol; 1977 Jun; 5(6):551-8. PubMed ID: 195975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysis of herpes simplex virus-infected cells early in the infectious cycle by human antiviral antibody and complement.
    Cromeans TL; Shore SL
    Infect Immun; 1981 Mar; 31(3):1054-61. PubMed ID: 6262246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of virus-specific antigens in extracts from herpes simplex virus-infected cells by a Cr release inhibition test.
    Kutinová L; Vonka V
    Infect Immun; 1978 Jun; 20(3):587-91. PubMed ID: 78899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus microneutralization: a simplification of the test.
    Stalder H; Oxman MN; Herrmann KL
    J Infect Dis; 1975 Apr; 131(4):423-30. PubMed ID: 163870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme immunoassay for measurement of antibodies to herpes simplex virus infection: comparison with complement fixation, immunofluorescent-antibody, and neutralization techniques.
    Denoyel GA; Gaspar A; Nouyrigat C
    J Clin Microbiol; 1980 Feb; 11(2):114-9. PubMed ID: 6244329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of type-specific antibody to herpes simplex virus type 1 and 2 in human sera by complement-fixation tests.
    Skinner GR; Hartley CH; Whitney JE
    Arch Virol; 1976; 50(4):323-33. PubMed ID: 179502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Typing herpes simplex virus antibodies by complement-dependent antibody lysis of infected cells.
    Seth P; Kesavalu L
    Indian J Med Res; 1980 Apr; 71():485-92. PubMed ID: 6248461
    [No Abstract]   [Full Text] [Related]  

  • 11. Thin-layer immunoassay for determination of antibodies to herpes simplex virus.
    Jeansson S; Elwing H; Nilsson LA
    J Clin Microbiol; 1979 Mar; 9(3):317-22. PubMed ID: 222798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirect hemagglutinating antibody response to Herpesvirus hominis types 1 and 2 in immunized laboratory animals and in natural infections of man.
    Back AF; Schmidt NJ
    Appl Microbiol; 1974 Sep; 28(3):392-9. PubMed ID: 4371513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitopes of herpes simplex virus type 1 glycoprotein B that bind type-common neutralizing antibodies elicit type-specific antibody-dependent cellular cytotoxicity.
    Sanchez-Pescador L; Paz P; Navarro D; Pereira L; Kohl S
    J Infect Dis; 1992 Sep; 166(3):623-7. PubMed ID: 1380051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the neutralizing antibody to herpes simplex virus. III. Detection of type-specific antibody by slow-reacting complement-requiring neutralizing antibody assay.
    Ohashi M; Ozaki Y
    Microbiol Immunol; 1982; 26(7):569-74. PubMed ID: 7132789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Type-specificity of slow-reacting complement-requiring neutralizing antibody (s-CRN antibody) to herpes simplex virus types 1 and 2 in rabbits].
    Sekine N
    Uirusu; 1983 Jun; 33(1):47-55. PubMed ID: 6316659
    [No Abstract]   [Full Text] [Related]  

  • 16. Augmentation of the neutralisation test for type 1 HSV: evidence of high representation of neutralising antibody in the adult community.
    Holmes PJ; Hallworth JA; Stocker DI; Skinner GR
    Med Microbiol Immunol; 1985; 174(4):167-75. PubMed ID: 2999572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Fc receptors in herpes simplex virus infection.
    Costa JC; Rabson AS
    Lancet; 1975 Jan; 1(7898):77-8. PubMed ID: 46027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A micro-neutralization system for detection of s-CRN antibody to herpes simplex virus.
    Yoshino K; Abe K
    Microbiol Immunol; 1981; 25(10):1037-46. PubMed ID: 6273697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonvirion antigens produced by herpes simplex viruses 1 and 2.
    Tarro G; Sabin AB
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1032-6. PubMed ID: 4352219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of indirect hemagglutination and indirect immunofluorescence tests with microneutralization tests for detection of type-specific Herpesvirus hominis antibody.
    Johnson LD; Fuccillo DA; Stalder H; Oxman MA; Fraser CE; Madden DL
    J Clin Microbiol; 1979 Mar; 9(3):384-90. PubMed ID: 222800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.